{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T05:58:18Z","timestamp":1770962298954,"version":"3.50.1"},"reference-count":121,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.clinthera.2009.07.009","type":"journal-article","created":{"date-parts":[[2009,8,19]],"date-time":"2009-08-19T08:25:15Z","timestamp":1250670315000},"page":"1426-1453","source":"Crossref","is-referenced-by-count":70,"special_numbering":"P1","title":["Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic\/noradrenergic antidepressants during pregnancy: A review"],"prefix":"10.1016","volume":"31","author":[{"given":"Marco","family":"Tuccori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arianna","family":"Testi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Antonioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Fornai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Montagnani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narcisa","family":"Ghisu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rocchina","family":"Colucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiberio","family":"Corona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corrado","family":"Blandizzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario Del","family":"Tacca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2009.07.009_bib1","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/bmj.323.7307.257","article-title":"Cohort study of depressed mood during pregnancy and after childbirth","volume":"323","author":"Evans","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2009.07.009_bib2","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1034\/j.1600-0412.2001.080003251.x","article-title":"Prevalence of depressive symptoms in late pregnancy and postpartum","volume":"80","author":"Josefsson","year":"2001","journal-title":"Acta Obstet Gynecol Scand."},{"key":"10.1016\/j.clinthera.2009.07.009_bib3","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1097\/00006842-200109000-00017","article-title":"Antepartum depressive symptomatology is associated with adverse obstetric and neonatal outcomes","volume":"63","author":"Chung","year":"2001","journal-title":"Psychosom Med."},{"key":"10.1016\/j.clinthera.2009.07.009_bib4","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1177\/070674370404901103","article-title":"Perinatal risks of untreated depression during pregnancy","volume":"49","author":"Bonari","year":"2004","journal-title":"Can J Psychiatry."},{"key":"10.1016\/j.clinthera.2009.07.009_bib5","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1542\/peds.105.4.880","article-title":"Use of psychoactive medication during pregnancy and possible effects on the fetus and newborn","volume":"105","year":"2000","journal-title":"Pediatrics."},{"key":"10.1016\/j.clinthera.2009.07.009_bib6","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00228-006-0177-0","article-title":"Prevalence and patterns of antidepressant drug use during pregnancy","volume":"62","author":"Ververs","year":"2006","journal-title":"Eur J Clin Pharmacol."},{"key":"10.1016\/j.clinthera.2009.07.009_bib7","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1365-2125.2007.03048.x","article-title":"Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands","volume":"65","author":"Bakker","year":"2008","journal-title":"Br J Clin Pharmacol."},{"key":"10.1016\/j.clinthera.2009.07.009_bib8","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/j.1471-0528.2007.01387.x","article-title":"Prevalence and predictors of antidepressant use in a cohort of pregnant women","volume":"114","author":"Ramos","year":"2007","journal-title":"BJOG"},{"key":"10.1016\/j.clinthera.2009.07.009_bib9","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2165\/00002018-200528070-00002","article-title":"Treatment with selective serotonin reuptake inhibitors in the third trimester of pregnancy: Effects on the infant","volume":"28","author":"Nordeng","year":"2005","journal-title":"Drug Saf."},{"key":"10.1016\/j.clinthera.2009.07.009_bib10","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/bdra.20327","article-title":"Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations","volume":"79","author":"K\u00e4ll\u00e9n","year":"2007","journal-title":"Birth Defects Res A Clin Mol Teratol."},{"key":"10.1016\/j.clinthera.2009.07.009_bib11","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2165\/00002018-200023030-00006","article-title":"Risk classification systems for drug use during pregnancy: Are they a reliable source of information?","volume":"23","author":"Addis","year":"2000","journal-title":"Drug Saf."},{"key":"10.1016\/j.clinthera.2009.07.009_bib12","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/jama.279.8.609","article-title":"Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: A prospective controlled multicenter study","volume":"279","author":"Kulin","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2009.07.009_bib13","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/tera.1420460407","article-title":"Serotonin as a regulator of cranio-facial morphogenesis: Site specific malformations following exposure to serotonin uptake inhibitors","volume":"46","author":"Shuey","year":"1992","journal-title":"Teratology."},{"key":"10.1016\/j.clinthera.2009.07.009_bib14","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1073\/pnas.92.16.7182","article-title":"Serotonin regulates mouse cranial neural crest migration","volume":"92","author":"Moiseiwitsch","year":"1995","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.clinthera.2009.07.009_bib15","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1523\/JNEUROSCI.03-10-01901.1983","article-title":"Storage of serotonin in vivo as a complex with serotonin-binding protein in central and peripheral serotonergic neurons","volume":"3","author":"Gershon","year":"1983","journal-title":"J Neurosci."},{"key":"10.1016\/j.clinthera.2009.07.009_bib16","first-page":"75","article-title":"Serotonin and morphogenesis. Transient expression of serotonin uptake and binding protein during craniofacial morphogenesis in the mouse","volume":"187","author":"Shuey","year":"1993","journal-title":"Anat Embryol (Berl)."},{"key":"10.1016\/j.clinthera.2009.07.009_bib17","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1056\/NEJM199701233360404","article-title":"Neurodevelopment of children exposed in utero to antidepressant drugs","volume":"336","author":"Nulman","year":"1997","journal-title":"N Engl J Med."},{"key":"10.1016\/j.clinthera.2009.07.009_bib18","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0890-6238(96)00057-3","article-title":"The outcome of pregnancy in 689 women exposed to therapeutic doses of antidepressants. A collaborative study of the European Network of Teratology Information Services (ENTIS)","volume":"10","author":"McElhatton","year":"1996","journal-title":"Reprod Toxicol."},{"key":"10.1016\/j.clinthera.2009.07.009_bib19","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s002280050664","article-title":"Delivery outcome after the use of anti-depressant in early pregnancy","volume":"55","author":"Ericson","year":"1999","journal-title":"Eur J Clin Pharmacol."},{"key":"10.1016\/j.clinthera.2009.07.009_bib20","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1056\/NEJM199610033351402","article-title":"Birth outcomes in pregnant women taking fluoxetine","volume":"335","author":"Chambers","year":"1996","journal-title":"N Engl J Med."},{"key":"10.1016\/j.clinthera.2009.07.009_bib21","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1001\/jama.269.17.2246","article-title":"Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac)","volume":"269","author":"Pastuszak","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2009.07.009_bib22","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0029-7844(97)00070-7","article-title":"Effects of first-trimester fluox-etine exposure on the newborn","volume":"89","author":"Goldstein","year":"1997","journal-title":"Obstet Gynecol."},{"key":"10.1016\/j.clinthera.2009.07.009_bib23","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1016\/j.ajog.2005.05.012","article-title":"Citalopram use in pregnancy: Prospective comparative evaluation of pregnancy and fetal outcome","volume":"193","author":"Sivojelezova","year":"2005","journal-title":"Am J Obstet Gynecol."},{"key":"10.1016\/j.clinthera.2009.07.009_bib24","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/jcp.0b013e31815ac4d2","article-title":"Delivery outcome in relation to maternal use of some recently introduced antide-pressants","volume":"27","author":"Lennest\u00e5l","year":"2007","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.clinthera.2009.07.009_bib25","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1471-0528.2007.01518.x","article-title":"Neonatal outcome following pregnancy exposure to antidepres-sants: A prospective controlled cohort study","volume":"115","author":"Maschi","year":"2008","journal-title":"BJOG"},{"key":"10.1016\/j.clinthera.2009.07.009_bib26","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1192\/bjp.bp.107.042523","article-title":"Duration of antidepressant use during pregnancy and risk of major congenital malformations","volume":"192","author":"Ramos","year":"2008","journal-title":"Br J Psychiatry."},{"key":"10.1016\/j.clinthera.2009.07.009_bib27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4065\/84.1.23","article-title":"Congenital heart disease associated with selective serotonin reuptake inhibitor use during pregnancy","volume":"84","author":"Wichman","year":"2009","journal-title":"Mayo Clin Proc."},{"key":"10.1016\/j.clinthera.2009.07.009_bib28","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1177\/070674370905400405","article-title":"Incidence of major malformations in infants following antidepressant exposure in pregnancy: Results of a large prospective cohort study","volume":"54","author":"Einarson","year":"2009","journal-title":"Can J Psychiatry."},{"key":"10.1016\/j.clinthera.2009.07.009_bib29","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/pds.1463","article-title":"Paroxetine in the first trimester and the prevalence of congenital malformations","volume":"16","author":"Cole","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"10.1016\/j.clinthera.2009.07.009_bib30","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/bdra.20327","article-title":"Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations","volume":"79","author":"K\u00e4ll\u00e9n","year":"2007","journal-title":"Birth Defects Res A Clin Mol Teratol."},{"key":"10.1016\/j.clinthera.2009.07.009_bib31","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/bdrb.20099","article-title":"First trimester exposure to paroxetine and risk of cardiac malformations in infants: The importance of dosage","volume":"80","author":"B\u00e9rard","year":"2007","journal-title":"Birth Defects Res B Dev Reprod Toxicol."},{"key":"10.1016\/j.clinthera.2009.07.009_bib32","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1056\/NEJMoa067407","article-title":"First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects","volume":"336","author":"Louik","year":"2007","journal-title":"N Engl J Med."},{"key":"10.1016\/j.clinthera.2009.07.009_bib33","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1056\/NEJMoa066584","article-title":"Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects","volume":"356","author":"Alwan","year":"2007","journal-title":"N Engl J Med."},{"key":"10.1016\/j.clinthera.2009.07.009_bib34","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/pds.1462","article-title":"Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy","volume":"16","author":"Davis","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"10.1016\/j.clinthera.2009.07.009_bib35","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/bdrb.20144","article-title":"Major congenital malformations following prenatal exposure to serotonin reuptake inhibitors and benzodiazepines using population-based health data","volume":"83","author":"Oberlander","year":"2008","journal-title":"Birth Defects Res B Dev Reprod Toxicol."},{"key":"10.1016\/j.clinthera.2009.07.009_bib36","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1365-2125.2008.03261.x","article-title":"Paroxetine and fluox-etine in pregnancy: A prospective, multicentre, controlled, observational study","volume":"66","author":"Diav-Citrin","year":"2008","journal-title":"Br J Clin Pharmacol."},{"key":"10.1016\/j.clinthera.2009.07.009_bib37","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1176\/appi.ajp.158.10.1728","article-title":"Pregnancy outcome following gestational exposure to venlafaxine: A multicenter prospective controlled study","volume":"158","author":"Einarson","year":"2001","journal-title":"Am J Psychiatry."},{"key":"10.1016\/j.clinthera.2009.07.009_bib38","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.4088\/JCP.v67n0817","article-title":"Exposure to mirtazapine during pregnancy: A prospective, comparative study of birth outcomes","volume":"67","author":"Djulus","year":"2006","journal-title":"J Clin Psychiatry."},{"key":"10.1016\/j.clinthera.2009.07.009_bib39","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1176\/appi.ajp.159.12.2055","article-title":"Outcomes of prenatal antidepressant exposure","volume":"159","author":"Simon","year":"2002","journal-title":"Am J Psychiatry."},{"key":"10.1016\/j.clinthera.2009.07.009_bib40","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1097\/01.AOG.0000187302.61812.53","article-title":"Risks associated with selective serotonin inhibitors in pregnancy","volume":"106","author":"Malm","year":"2005","journal-title":"Obstet Gynecol."},{"key":"10.1016\/j.clinthera.2009.07.009_bib41","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1176\/appi.ajp.2007.07060879","article-title":"Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy [published corrections appear in Am J Psychiatry. 2008;165:777, 1208]","volume":"165","author":"Einarson","year":"2008","journal-title":"Am J Psychiatry."},{"key":"10.1016\/j.clinthera.2009.07.009_bib42","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/01.ede.0000239581.76793.ae","article-title":"Maternal use of selective serotonin reuptake inhibitors and risk of congenital malformations","volume":"17","author":"Wogelius","year":"2006","journal-title":"Epidemiology."},{"key":"10.1016\/j.clinthera.2009.07.009_bib44","first-page":"4","article-title":"Paxil and the risk of birth defects","volume":"40","year":"2006","journal-title":"FDA Consum."},{"key":"10.1016\/j.clinthera.2009.07.009_bib45","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1503\/cmaj.051421","article-title":"Paroxetine (Paxil) and congenital malformations","volume":"173","author":"Williams","year":"2005","journal-title":"CMAJ"},{"key":"10.1016\/j.clinthera.2009.07.009_bib46","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/tera.1420470609","article-title":"Serotonin and cardiac morphogenesis in the mouse embryo","volume":"47","author":"Yavarone","year":"1993","journal-title":"Teratology."},{"key":"10.1016\/j.clinthera.2009.07.009_bib47","doi-asserted-by":"crossref","first-page":"e2782","DOI":"10.1371\/journal.pone.0002782","article-title":"Modulation of serotonin transporter function during fetal development causes dilated heart cardiomyopathy and lifelong behavioral abnormalities","volume":"3","author":"Noorlander","year":"2008","journal-title":"PLoS ONE."},{"key":"10.1016\/j.clinthera.2009.07.009_bib49","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1017\/S0033291799001270","article-title":"Safety of fluoxetine during the first trimester of pregnancy: A meta-analytical review of epidemiological studies","volume":"30","author":"Addis","year":"2000","journal-title":"Psychol Med."},{"key":"10.1016\/j.clinthera.2009.07.009_bib50","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/pds.1084","article-title":"Newer antidepressants in pregnancy and rates of major malformations: A meta-analysis of prospective comparative studies","volume":"14","author":"Einarson","year":"2005","journal-title":"Pharmacoepidemiol Drugsaf."},{"key":"10.1016\/j.clinthera.2009.07.009_bib51","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.reprotox.2006.03.019","article-title":"Pregnancy outcomes following exposure to serotonin reuptake inhibitors: A meta-analysis of clinical trials","volume":"22","author":"Rahimi","year":"2006","journal-title":"Reprod Toxicol."},{"key":"10.1016\/j.clinthera.2009.07.009_bib52","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.clinthera.2007.05.003","article-title":"Paroxetine and congenital malformations: Meta-analysis and consideration of potential confounding factors","volume":"29","author":"Bar-Oz","year":"2007","journal-title":"Clin Ther."},{"key":"10.1016\/j.clinthera.2009.07.009_bib53","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S1701-2163(16)32918-8","article-title":"Does paroxetine cause cardiac malformations?","volume":"30","author":"O\u2019Brien","year":"2008","journal-title":"J Obstet Gynaecol Can."},{"key":"10.1016\/j.clinthera.2009.07.009_bib54","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1741-4520.2008.00189.x","article-title":"Specified critical period of different congenital abnormalities: A new approach for human teratological studies","volume":"48","author":"Czeizel","year":"2008","journal-title":"Congenit Anom (Kyoto)"},{"key":"10.1016\/j.clinthera.2009.07.009_bib55","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1097\/00006250-200612000-00058","article-title":"ACOG Committee Opinion No. 354: Treatment with selective serotonin reuptake inhibitors during pregnancy","volume":"108","year":"2006","journal-title":"Obstet Gynecol."},{"key":"10.1016\/j.clinthera.2009.07.009_bib58","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0022-3476(64)80188-8","article-title":"Congenital anomalies in the newborn infant, including minor variations. A study of 4,412 babies by surface examination for anomalies and buccal smear for sex chromatin","volume":"64","author":"Marden","year":"1964","journal-title":"J Pediatr."},{"key":"10.1016\/j.clinthera.2009.07.009_bib59","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1067\/mpd.2003.139","article-title":"Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy","volume":"142","author":"Casper","year":"2003","journal-title":"J Pediatr."},{"key":"10.1016\/j.clinthera.2009.07.009_bib60","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0028-2243(79)90003-0","article-title":"5-Hydroxy-tryptamine (serotonin), copper and ceruloplasmin plasma concentrations in spontaneous abortion","volume":"9","author":"Bassiouni","year":"1979","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"key":"10.1016\/j.clinthera.2009.07.009_bib61","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1345\/aph.1E547","article-title":"Antidepressant use during pregnancy and the rates of spontaneous abortions: A meta-analysis","volume":"39","author":"Hemels","year":"2005","journal-title":"Ann Pharmacother."},{"key":"10.1016\/j.clinthera.2009.07.009_bib62","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1001\/jama.293.19.2372","article-title":"Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: Literature review and implications for clinical applications","volume":"293","author":"Moses-Kolko","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2009.07.009_bib63","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1080\/080352501300067596","article-title":"Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors","volume":"90","author":"Nordeng","year":"2001","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.clinthera.2009.07.009_bib64","doi-asserted-by":"crossref","first-page":"F77","DOI":"10.1136\/fn.84.1.F77a","article-title":"Withdrawal reactions of a premature neonate after maternal use of paroxetine","volume":"84","author":"Nijhuis","year":"2001","journal-title":"Arch Dis Child Fetal Neonatal Ed."},{"key":"10.1016\/j.clinthera.2009.07.009_bib65","doi-asserted-by":"crossref","first-page":"F134","DOI":"10.1136\/fn.84.2.F134","article-title":"Neonatal paroxetine withdrawal syndrome","volume":"84","author":"Stiskal","year":"2001","journal-title":"Arch Dis Child Fetal Neonatal Ed."},{"key":"10.1016\/j.clinthera.2009.07.009_bib66","first-page":"232","article-title":"Paroxetine withdrawal syndrome as differential diagnosis of acute neonatal encephalopathy [in German]?","volume":"207","author":"Herbst","year":"2003","journal-title":"Z Geburtshilfe Neonatol."},{"key":"10.1016\/j.clinthera.2009.07.009_bib67","first-page":"660","article-title":"Neonatal withdrawal syndrome to selective serotonin reuptake inhibitors: Case report and literature review [in Spanish]","volume":"42","author":"Agut-Quijano","year":"2006","journal-title":"Rev Neurol."},{"key":"10.1016\/j.clinthera.2009.07.009_bib68","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1192\/bjp.171.4.391c","article-title":"Paroxetine withdrawal syndrome in a neonate","volume":"171","author":"Dahl","year":"1997","journal-title":"Br J Psychiatry."},{"key":"10.1016\/j.clinthera.2009.07.009_bib69","first-page":"66","article-title":"Fluoxetine withdrawal syndrome in the newborn","volume":"4381","author":"Anbu","year":"2006","journal-title":"Indian Pediatr."},{"key":"10.1016\/j.clinthera.2009.07.009_bib70","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1542\/peds.92.5.721","article-title":"Fluoxetine hydrochloride (Prozac) toxicity in a neonate","volume":"92","author":"Spencer","year":"1993","journal-title":"Pediatrics."},{"key":"10.1016\/j.clinthera.2009.07.009_bib71","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1542\/peds.100.1.158","article-title":"Potential fluoxetine chloride (Prozac) toxicity in a newborn","volume":"100","author":"Mhanna","year":"1997","journal-title":"Pediatrics."},{"key":"10.1016\/j.clinthera.2009.07.009_bib72","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1177\/000992280104001207","article-title":"Fluoxetine toxicity in a breastfed infant","volume":"40","author":"Hale","year":"2001","journal-title":"Clin Pediatr (Phila)."},{"key":"10.1016\/j.clinthera.2009.07.009_bib73","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3928\/00904481-20080301-02","article-title":"Poor neonatal adaptation in term infant. Fluoxetine toxicity","volume":"37","author":"Kwon","year":"2008","journal-title":"Pediatr Ann."},{"key":"10.1016\/j.clinthera.2009.07.009_bib74","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1192\/bjp.167.3.412b","article-title":"Suspected congenital sertraline dependence","volume":"167","author":"Kent","year":"1995","journal-title":"Br J Psychiatry."},{"key":"10.1016\/j.clinthera.2009.07.009_bib75","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/sj.jp.7211115","article-title":"Transient neonatal jitteriness due to maternal use of sertraline (Zoloft)","volume":"24","author":"Santos","year":"2004","journal-title":"J Perinatol."},{"key":"10.1016\/j.clinthera.2009.07.009_bib76","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3928\/00904481-20080301-01","article-title":"Neonatal extrapyramidal movements. Neonatal withdrawal due to maternal citalo-pram and ondansetron use","volume":"37","author":"Kwon","year":"2008","journal-title":"Pediatr Ann."},{"key":"10.1016\/j.clinthera.2009.07.009_bib77","first-page":"1370","article-title":"Withdrawal symptoms in a neonate following exposure to venlafaxine during pregnancy [in Dutch]","volume":"147","author":"de Moor","year":"2003","journal-title":"Ned Tijdschr Geneeskd."},{"key":"10.1016\/j.clinthera.2009.07.009_bib78","first-page":"e188","article-title":"Neonatal recurrent prolonged hypothermia associated with maternal mirtazapine treatment during pregnancy","volume":"15","author":"Sokolover","year":"2008","journal-title":"Can J Clin Pharmacol."},{"key":"10.1016\/j.clinthera.2009.07.009_bib79","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1176\/appi.ajp.2008.07071194","article-title":"Poor neonatal adaptation after in utero exposure to duloxetine","volume":"165","author":"Eyal","year":"2008","journal-title":"Am J Psychiatry."},{"key":"10.1016\/j.clinthera.2009.07.009_bib80","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0140-6736(05)17865-9","article-title":"Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: A database analysis","volume":"365","author":"Sanz","year":"2005","journal-title":"Lancet."},{"key":"10.1016\/j.clinthera.2009.07.009_bib81","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1001\/archpedi.156.11.1129","article-title":"Perinatal outcome following third trimester exposure to paroxetine","volume":"156","author":"Costei","year":"2002","journal-title":"Arch Pediatr Adolesc Med."},{"key":"10.1016\/j.clinthera.2009.07.009_bib82","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1001\/archpsyc.60.7.720","article-title":"Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations","volume":"60","author":"Laine","year":"2003","journal-title":"Arch Gen Psychiatry."},{"key":"10.1016\/j.clinthera.2009.07.009_bib83","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/S0006-3223(00)00877-5","article-title":"Birth outcomes following perinatal exposure to fluoxetine","volume":"48","author":"Cohen","year":"2000","journal-title":"Biol Psychiatry."},{"key":"10.1016\/j.clinthera.2009.07.009_bib84","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/00004714-199512000-00005","article-title":"Effects of third trimester fluoxetine exposure on the newborn","volume":"15","author":"Goldstein","year":"1995","journal-title":"J Clin Psychopharmacol."},{"key":"10.1016\/j.clinthera.2009.07.009_bib85","doi-asserted-by":"crossref","first-page":"230","DOI":"10.4088\/JCP.v65n0214","article-title":"Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure","volume":"65","author":"Oberlander","year":"2004","journal-title":"J Clin Psychiatry."},{"key":"10.1016\/j.clinthera.2009.07.009_bib86","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1001\/archpedi.158.4.312","article-title":"Neonate characteristics after maternal use of antidepressants in late pregnancy","volume":"158","author":"K\u00e4ll\u00e9n","year":"2004","journal-title":"Arch Pediatr Adolesc Med."},{"key":"10.1016\/j.clinthera.2009.07.009_bib87","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1542\/peds.113.2.368","article-title":"Maternal selective reuptake inhibitor use during pregnancy and newborn neuro-behavior","volume":"113","author":"Zeskind","year":"2004","journal-title":"Pediatrics."},{"key":"10.1016\/j.clinthera.2009.07.009_bib88","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1176\/appi.ajp.160.5.993","article-title":"Placental passage of antidepressant medications","volume":"160","author":"Hendrick","year":"2003","journal-title":"Am J Psychiatry."},{"key":"10.1016\/j.clinthera.2009.07.009_bib89","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1001\/archpsyc.63.8.898","article-title":"Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data","volume":"63","author":"Oberlander","year":"2006","journal-title":"Arch Gen Psychiatry."},{"key":"10.1016\/j.clinthera.2009.07.009_bib90","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1542\/peds.2006-2133","article-title":"Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates","volume":"119","author":"Ferreira","year":"2007","journal-title":"Pediatrics."},{"key":"10.1016\/j.clinthera.2009.07.009_bib91","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.4088\/JCP.v68n0817","article-title":"Birth outcomes following prenatal exposure to antide-pressants","volume":"68","author":"Pearson","year":"2007","journal-title":"J Clin Psychiatry."},{"key":"10.1016\/j.clinthera.2009.07.009_bib92","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1176\/appi.ajp.2007.06071172","article-title":"Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth","volume":"164","author":"Suri","year":"2007","journal-title":"Am J Psychiatry."},{"key":"10.1016\/j.clinthera.2009.07.009_bib93","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/JCP.0b013e318173aa2e","article-title":"A new look at the neonate's clinical presentation after in utero exposure to antidepressants in late pregnancy","volume":"28","author":"Boucher","year":"2008","journal-title":"J Clin Psychopharmacol."},{"key":"10.1016\/j.clinthera.2009.07.009_bib94","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1080\/14767050802255488","article-title":"Serotonin reuptake inhibitor use in pregnancy and the neonatal behavioral syndrome","volume":"21","author":"Jordan","year":"2008","journal-title":"J Matern Fetal Neonatal Med."},{"key":"10.1016\/j.clinthera.2009.07.009_bib95","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1192\/bjp.bp.107.037101","article-title":"Effects of timing and duration of gestational exposure to serotonin reuptake inhibitor antidepressants: Population-based study","volume":"192","author":"Oberlander","year":"2008","journal-title":"Br J Psychiatry."},{"issue":"Suppl B","key":"10.1016\/j.clinthera.2009.07.009_bib96","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1177\/0269881198012003021","article-title":"Selective serotonin reuptake inhibitors in affective disorders\u2014I. Basic pharmacology","volume":"12","author":"Goodnick","year":"1998","journal-title":"J Psychopharmacol."},{"key":"10.1016\/j.clinthera.2009.07.009_bib97","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2125.2005.02538.x","article-title":"Stereoselective disposition of fluoxetine and norfluoxetine during pregnancy and breast-feeding","volume":"61","author":"Kim","year":"2006","journal-title":"Br J Clin Pharmacol."},{"key":"10.1016\/j.clinthera.2009.07.009_bib98","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.resp.2005.01.011","article-title":"Neurochemical development of brain stem nuclei involved in the control of respiration","volume":"149","author":"Wong-Riley","year":"2005","journal-title":"Respir Physiol Neurobiol."},{"key":"10.1016\/j.clinthera.2009.07.009_bib99","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0006-3223(98)00139-5","article-title":"The spectrum of behaviors influenced by serotonin","volume":"44","author":"Lucki","year":"1998","journal-title":"Biol Psychiatry."},{"issue":"Suppl","key":"10.1016\/j.clinthera.2009.07.009_bib100","doi-asserted-by":"crossref","first-page":"33S","DOI":"10.1016\/S0893-133X(99)00022-6","article-title":"Serotonin neurons, neuroplasticity, and homeostasis of neural tissue","volume":"21","author":"Azmitia","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.clinthera.2009.07.009_bib101","doi-asserted-by":"crossref","first-page":"12331","DOI":"10.1073\/pnas.1933740100","article-title":"Induction of pulmonary hypertension by an angiopoietin 1\/TIE2\/serotonin pathway","volume":"100","author":"Sullivan","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clinthera.2009.07.009_bib102","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1053\/j.semperi.2005.02.003","article-title":"The diseases treated with ECMO: Focus on PPHN","volume":"29","author":"Farrow","year":"2005","journal-title":"Semin Perinatol."},{"key":"10.1016\/j.clinthera.2009.07.009_bib103","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1542\/peds.105.1.14","article-title":"Persistent pulmonary hypertension of the newborn in the era before nitric oxide: Practice variation and outcomes","volume":"105","author":"Walsh-Sukys","year":"2000","journal-title":"Pediatrics."},{"key":"10.1016\/j.clinthera.2009.07.009_bib104","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1067\/mlc.2002.122181","article-title":"Is the serotonin transporter involved in the pathogenesis of pulmonary hypertension","volume":"139","author":"Eddahibi","year":"2002","journal-title":"J Lab Clin Med."},{"key":"10.1016\/j.clinthera.2009.07.009_bib105","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1164\/rccm.200701-163OC","article-title":"Prenatal exposure to fluoxetine induces fetal pulmonary hypertension in the rat","volume":"176","author":"Fornaro","year":"2007","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.clinthera.2009.07.009_bib106","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/ppul.20201","article-title":"Pathophysiologic mechanisms of persistent pulmonary hypertension of the newborn","volume":"39","author":"Dakshinamurti","year":"2005","journal-title":"Pediatr Pulmonol."},{"key":"10.1016\/j.clinthera.2009.07.009_bib107","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1056\/NEJMoa052744","article-title":"Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn","volume":"354","author":"Chambers","year":"2006","journal-title":"N Engl J Med."},{"key":"10.1016\/j.clinthera.2009.07.009_bib108","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/pds.1570","article-title":"Maternal use of selective serotonin reuptake inhbitors and persistent pulmonary hypertension of the newborn","volume":"17","author":"K\u00e4llen","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"10.1016\/j.clinthera.2009.07.009_bib109","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/pds.1710","article-title":"Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn","volume":"18","author":"Andrade","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"10.1016\/j.clinthera.2009.07.009_bib110","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1176\/appi.ajp.159.11.1889","article-title":"Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: A prospective, controlled study","volume":"159","author":"Nulman","year":"2002","journal-title":"Am J Psychiatry."},{"key":"10.1016\/j.clinthera.2009.07.009_bib111","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1001\/archpedi.161.1.22","article-title":"Externalizing and attentional behaviors in children of depressed mothers treated with a selective serotonin reuptake inhibitor antidepressant during pregnancy","volume":"161","author":"Oberlander","year":"2007","journal-title":"Arch Pediatr Adolesc Med."},{"key":"10.1016\/j.clinthera.2009.07.009_bib112","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1023\/A:1025306304635","article-title":"Psychomotor development in children exposed in utero to benzodiazepines, antidepressants, neuroleptics, and antiepileptics","volume":"18","author":"Mortensen","year":"2003","journal-title":"Eur J Epidemiol."},{"key":"10.1016\/j.clinthera.2009.07.009_bib113","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1365-2796.2006.01720.x","article-title":"Clinical impact of selective serotonin reuptake inhibitors therapy with bleeding risks","volume":"261","author":"Turner","year":"2007","journal-title":"J Intern Med."},{"key":"10.1016\/j.clinthera.2009.07.009_bib114","series-title":"Nelson Textbook of Pediatrics","first-page":"466","article-title":"Intracranial (intra-ventricular) hemorrhage","author":"Kliegman","year":"1996"},{"key":"10.1016\/j.clinthera.2009.07.009_bib115","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/sj.jp.7200388","article-title":"Fluoxetine toxicity in a preterm infant","volume":"20","author":"Mohan","year":"2000","journal-title":"J Perinatol."},{"key":"10.1016\/j.clinthera.2009.07.009_bib116","first-page":"724","article-title":"Neonatal convulsions and subarachnoid hemorrhage after in utero exposure to paroxetine [in Spanish]","volume":"36","author":"Salvia-Roig\u00e9s","year":"2003","journal-title":"Rev Neurol."},{"key":"10.1016\/j.clinthera.2009.07.009_bib117","first-page":"953","volume":"7","author":"Paroxetine","year":"1997","journal-title":"Can Adverse Drug Reaction Newslett"},{"key":"10.1016\/j.clinthera.2009.07.009_bib118","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1046\/j.1365-2125.2003.01906.x","article-title":"Neonatal intra-ventricular haemorrhage associated with maternal use of parox-etine","volume":"56","author":"Duijvestijn","year":"2003","journal-title":"Br J Clin Pharmacol."},{"key":"10.1016\/j.clinthera.2009.07.009_bib119","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1017\/S0317167100004224","article-title":"A follow-up study of infants with intracranial hemorrhage at full-term","volume":"32","author":"Jhawar","year":"2005","journal-title":"Can J Neurol Sci."},{"key":"10.1016\/j.clinthera.2009.07.009_bib120","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000090929","article-title":"Maternal selective serotonin reuptake inhibitor intake does not seem to affect neonatal platelet function tests","volume":"115","author":"Maayan-Metzger","year":"2006","journal-title":"Acta Haematol."},{"key":"10.1016\/j.clinthera.2009.07.009_bib121","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/JCP.0b013e318166c52e","article-title":"The risk of postpartum hemorrhage with selective serotonin reuptake inhibitors and other antidepressants","volume":"28","author":"Salkeld","year":"2008","journal-title":"J Clin Psychopharmacol."},{"issue":"Suppl K","key":"10.1016\/j.clinthera.2009.07.009_bib122","doi-asserted-by":"crossref","first-page":"K70","DOI":"10.1016\/S1520-765X(01)90009-4","article-title":"Spectrum of drugs prolonging QT interval and the incidence of torsades de pointes","volume":"3","author":"Darp\u00f6","year":"2001","journal-title":"Eur HeartJ."},{"key":"10.1016\/j.clinthera.2009.07.009_bib123","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0014-5793(01)03320-8","article-title":"Inhibitory actions of the selective serotonin reuptake inhibitor citalopram on HERG and ventricular L-type calcium currents","volume":"512","author":"Witchel","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.clinthera.2009.07.009_bib124","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1136\/adc.2004.064618","article-title":"Prolonged QT interval in an infant of a fluoxetine-treated mother","volume":"90","author":"Dubnov","year":"2005","journal-title":"Arch Dis Child."},{"key":"10.1016\/j.clinthera.2009.07.009_bib125","doi-asserted-by":"crossref","first-page":"e710","DOI":"10.1542\/peds.2008-0658","article-title":"Antenatal use of selective serotonin-reuptake inhibitors and QT interval prolongation in newborns","volume":"122","author":"Dubnov-Raz","year":"2008","journal-title":"Pediatrics."}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291809002082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291809002082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T23:09:55Z","timestamp":1710544195000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291809002082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":121,"alternative-id":["S0149291809002082"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2009.07.009","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}